Erinacines: Key Bioactive Compounds and Their Functions in Lion’s Mane Mycelium
— THE HOOK —
Lion's Mane contains two families of NGF-stimulating compounds. Hericenon resides in the fruiting body. So what does the mycelium hold?
Answer: Erinacin.
Discovered in 1994, a second compound family built on a different chemical scaffold from Hericenon yet aimed at the same target — NGF synthesis. And according to some researchers, more potent than Hericenon in NGF stimulation.
— WHAT IS ERINACIN? —
Erinacin is a family of diterpenoids isolated from Hericium erinaceus mycelium. It was characterized by Kawagishi and colleagues in 1994 — three years after the discovery of Hericenon.
To date, multiple variants from Erinacin A through I have been identified. Among these, Erinacin A has been reported as the most potent NGF stimulator.
Reference: Kawagishi, H. et al. (1994). Erinacines A, B and C, strong stimulators of nerve growth factor synthesis, from the mushroom Hericium erinaceus. Tetrahedron Letters, 35(10).
— MECHANISM —
Erinacin operates through a mechanism similar to but distinct from that of Hericenon.
Both compounds stimulate astrocytes to trigger endogenous NGF production. However, Erinacin's chemical structure is built upon a cyathane diterpenoid skeleton — a scaffold that differs from the one underlying Hericenon.
In comparative in vitro studies, Erinacin A has been reported to stimulate NGF synthesis at lower concentrations than Hericenon C. This suggests Erinacin may be more potent on a per-gram basis.
However: This is in vitro data. Within the human body, factors such as bioavailability, metabolism, and blood-brain barrier penetration enter the equation. Which compound proves more effective in a clinical setting has not yet been determined.
— ERINACIN vs. HERICENON —
Source: Erinacin → mycelium. Hericenon → fruiting body.
Chemical structure: Erinacin → cyathane diterpenoid. Hericenon → distinct diterpenoid skeleton.
NGF potency (in vitro): Erinacin A > Hericenon C (active at lower concentrations)
Clinical data: Limited for both. The Mori (2009) study used whole fruiting body — meaning a Hericenon-containing formulation.
Bioavailability: Both are lipophilic (fat-soluble). Absorption may be enhanced with a lipid-containing carrier.
— THE FRUITING BODY vs. MYCELIUM DEBATE —
This compound-level distinction feeds into one of the largest controversies in the mushroom powder industry: fruiting body or mycelium?
Mycelium advocates point to Erinacin's potency. Fruiting body proponents emphasize not only Hericenon but also the broader diversity of bioactive compounds — beta-glucan, ergothioneine, and others.
The MYCOVITA approach: 100% fruiting body. The reason is not that Erinacin is weak — it is that the fruiting body offers a wider spectrum of constituents, and most mycelium-based products on the market are contaminated with grain substrate.
An honest note: In an ideal world, a product containing both Hericenon and Erinacin would offer the most comprehensive profile. Yet most mycelium products on the market are not pure mycelium — they are mycelium-on-grain mixtures — and the actual Erinacin concentration in such mixtures is rarely quantified.
— THE RESEARCH —
Kawagishi, H. et al. (1994): The first study demonstrating that Erinacines A, B, and C strongly stimulate NGF synthesis.
Lee, K.F. et al. (2014): A study showing neuroprotective effects of Erinacin A in animal models. A protective effect was reported in an ischemic brain injury model.
Li, I.C. et al. (2018): A pilot study examining the effect of Hericium erinaceus mycelium supplementation on cognitive function in patients with mild Alzheimer's disease.
Candid assessment: Erinacin research is newer and less extensive than Hericenon research. Large-scale human clinical trials are not yet available. Promising, but early-stage.
You May Also Be Interested In
→ What Is Hericenon? — The Fruiting Body's NGF Compound
→ What Is NGF? — Nerve Growth Factor
→ MIND | Lion's Mane — Species Encyclopedia
→ Mycelium vs. Fruiting Body — What Is the Difference?
→ The Brain-Gut Axis and Lion's Mane
The NGF Axis — Related Resources
A structured content cluster on the Lion's Mane neurotrophic pathway:
- Lion's Mane Species Encyclopedia — The full species profile.
- Hericenon — NGF synthesis stimulators in the fruiting body.
- Erinacin — The blood-brain barrier-crossing form in mycelium.
- NGF — The biological role of nerve growth factor.
- The Brain-Gut Axis — Enteric nervous system interactions.
- 30-Day Profile — Timeline of the neurotrophic process.
- Nootropic Stack — Combination assessment with other compounds.
Further Reading
- What Is Hericenon and Its NGF Role in Lion's Mane Mushroom — What Is Hericenon and Its NGF Role in Lion's Mane Mushroom
- Lion's Mane (Hericium erinaceus) Species Encyclopedia — Lion's Mane (Hericium erinaceus) Species Encyclopedia
- Lion's Mane Mushroom and Brain-Gut Axis Research — Lion's Mane Mushroom and Brain-Gut Axis Research
This content is for informational purposes only and does not constitute medical advice. Consult your physician before making any health-related decisions. Functional mushrooms are not drugs and cannot be used to treat diseases.
Version: 1.0 | Last updated: 20 Apr 2026 | Sources reviewed: 8+ | Methodology: Editorial Policy | References: Bibliography